Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Opinion in Oncology|July 19, 2018
Reappraisal of eligibility criteria in cancer clinical trialsNicolas Penel, Loïc Lebellec, Marie Vanseymortier
Bulletin Du Cancer|March 20, 2019
[Evolution of the regulatory framework in clinical research]Marie Vanseymortier, Julien Thery, Nicolas Penel
Investigational New Drugs|September 25, 2007
Prognostic factors among cancer patients with good performance status screened for phase I trialsNicolas Penel, Marie Vanseymortier, Marie-Edith Bonneterre, et al.
Critical Reviews in Oncology/Hematology|June 22, 2016
Reporting adverse events in cancer surgery randomized trials: A systematic review of published trials in oesophago-gastric and gynecological cancer patientsLeila Meghelli, Fabrice Narducci, Christophe Mariette, et al.
International Journal of Cancer|January 17, 2022
Is ovarian recovery after chemotherapy in young patients with early breast cancer influenced by controlled ovarian hyperstimulation for fertility preservation or tumor characteristics? Results of a prospective study in 126 patientsAudrey Mailliez, Pascal Pigny, Emilie Bogart, et al.
BMC Cancer|April 18, 2015
Study protocol of REGOSARC trial: activity and safety of regorafenib in advanced soft tissue sarcoma: a multinational, randomized, placebo-controlled, phase II trialThomas Brodowicz, Bernadette Liegl-Atzwager, Emmanuelle Tresch, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 15, 2026
FIMBRIMENOP-2402 trial: evaluating fimbriectomy with delayed oophorectomy in patients with high-risk tubo-ovarian cancerSophie Schoenen, Audrey Mailliez, Séverine Risbourg, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2020
A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanibNicolas Penel, Olivier Mir, Jennifer Wallet, et al.
Pageof 1